期刊文献+

血浆脂联素和B型钠尿肽水平在慢性充血性心力衰竭患者心功能评价中的价值 被引量:7

CLINICAL SIGNIFICANCE OF PLASMA ADIPONECTIN AND B-TYPE NATRIURETIC PEPTIDE FOR EVALUATING THE CARDIAC FUNCTION IN PATIENTS WITH CHRONIC CONGESTIVE HEART FAILURE
暂未订购
导出
摘要 目的探讨血浆脂联素(plasma adiponectin,APN)和B型钠尿肽(B-type natriuretic peptide,BNP)检测对慢性充血性心力衰竭(congestive heart failure,CHF)患者心功能评价的作用及临床价值。方法采用双抗体夹心ELISA法检测100例CHF患者治疗前后和30例非CHF(对照组)患者APN和BNP水平,分析APN、BNP水平与心功能分级的关系。结果心功能Ⅱ~Ⅳ患者APN、BNP水平显著上升,与对照组比较差异有统计学意义(P<0.05);APN、BNP水平随着心功能分级增高而逐渐上升,各级间比较差异有统计学意义(P<0.05);治疗后心功能Ⅱ~Ⅳ级组患者APN、BNP水平显著下降,与治疗前比较差异有统计学意义(P<0.05);CHF患者血浆APN、BNP水平与CHF患者心功能级别呈线性相关性(r=0.887、0.984,P<0.01)。结论 CHF患者血浆APN、BNP水平与心力衰竭严重程度密切相关,APN、BNP水平变化可做为评价CHF治疗效果的临床指标。 Objective To investigate the change and clinical significance of plasma adiponectin (APN) and B-type natriuretie peptide(BNP) for evaluating the cardiac function in patients with chronic congestive heart failure(CHF). Methods The plasma APN and BNP levels of 100 patients with chronic CHF and 30 patients with non-CHF was measured by double antibody sandwich ELISA method. The correlation of APN, BNP levels and cardiac function were analyzed. Results The plasma APN and BNP levels of patients with cardiac function Ⅱ~Ⅳ significantly increased, compared with the control group and the difference was significant ( P 〈 0. 05 ) ; The plasma APN and BNP levels of CHF patients increased with the increasing of cardiac function classification, the differences were significant between different level of cardiac function ( P 〈 0.05 ) ; After treatment, the plasma APN and BNP levels of patients with cardiac function ]Ⅱ~Ⅳ were significantly decreased, compared with pre-treatment and the differences were significant(P 〈0.05). The plasma APN and BNP levels of patients with CHF showed a linear correlation with the cardiac function ( r = 0. 887,0.984, P 〈 0.01 ). Conclusion The plasma APN and BNP levels of CHF patients are closely related to the severity of heart failure, the plasma APN and BNP levels can be used as clinical indicators for evaluating the therapeutic effect of patients with chronic CHF.
作者 徐公民
出处 《河北医科大学学报》 CAS 2013年第3期259-262,共4页 Journal of Hebei Medical University
关键词 心力衰竭 充血性 脂联素 心钠素 heart failure, congestive adiponectin atrial natriuretic faotor
  • 相关文献

参考文献18

  • 1侯东明,邱育红.氟伐他汀对慢性心力衰竭患者心功能及预后的影响[J].现代生物医学进展,2010,10(14):2708-2710. 被引量:2
  • 2中华医学会心血管病学分会 中华心血管病杂志编辑委员会.慢性心力衰竭诊断治疗建议.中华心血管病杂志,2007,35(12):1076-1095.
  • 3BOILSON BA, RAICHLIN E,PARK SJ,et al. Device therapy and cardiac transplantation for end-stage heart failure [ J ]. Curr Probl Cardiol,2010,35 ( 1 ) :8 - 11.
  • 4ERHARDT LR. A review of the current evidence for the use of angiotensin-receptor blockers in chronic heart failure [ J ]. Int J Clin Pract ,2005,59 ( 5 ) :571 - 578.
  • 5OPASICH C, CAZZOLA M, SCELSI L, et al. Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure[ J]. Eur Heart J,2005,26(21 ) :2232 -2237.
  • 6TAKAO H, OBATA JE, KODAMA Y, et al. Adiponectin is released from the heart in patients with heart failure [ J ]. Int J Cardio1,2009,132 (2) :221 - 226.
  • 7LORD E, LEDOUX S, MURPHY BD, et al. Expression of adiponeetin and its receptors in swine [ J ]. J Anim Sci, 2005,83 (3) :565 -578.
  • 8FU Y,LUO N, KLEIN RL, et al. Adiponectin promotes adipocyte differentiation, insulin sensitivity and lipid accumulation [ J ]. Lipid Res,2005,46(7) :1369 - 1379.
  • 9周淑娴,雷娟,张玉玲,方昶,罗年桑.高血压患者胰岛素抵抗与血清脂联素及炎症标志物水平[J].中华高血压杂志,2008,16(2):166-170. 被引量:41
  • 10郭飞舟,黄善强.血清脂联素、超敏C反应蛋白与2型糖尿病动脉粥样硬化病变程度的相关性研究[J].河北医科大学学报,2010,31(12):1471-1473. 被引量:4

二级参考文献51

共引文献83

同被引文献66

  • 1BLAKE GJ, RIDKER PM. Inflammatory bio:makers and cardiovascular risk prediction [ J ]. J Inter Med, 2002,25 ( 4 ) : 283 - 294.
  • 2NONOGAKI K, FULLER GM, FUENTES NL, et al. Interleukin-6 stimulates hepatic triglyceride secretion in rats [ J ]. Endocrinology, 1995,136 (5) :2143 - 2149.
  • 3HARRIS TB,FERRUCCI L,TRACY RP, et al. Associated with elevated interleukin-6 and C-reactive protein levels with mortality in old elderly [J]. Am J Med,1999,106(5) :506 -512.
  • 4WOLK R, BBERGER P, LENNON PO, et al. Association between plasma adiponectin levels and unstable coronary syndromes [ J ]. Eru Heart,2007,28 (3) :292 - 298.
  • 5NAKAMURA Y, SHIMADA K, FUKUDA D, et al. Implications of plasma concentrations of adiponectin in patients with coronary artery disease [ J ]. Heart,2004,90 ( 5 ) :528 - 533.
  • 6TIAN L, LUO N, KLEIN RL, et al. Adiponeetin reduces lipid aeeumulation in maerophage foam cells [ J ]. Atheroselerosis, 2009,202( 1 ) :152 - 161.
  • 7SCHULZE MB,SHAI I, RIMM EB, et al. Adiponectin and future coronary heart disease events among men with type 2 diabetes [ J ]. Diabetes,2005,54 (2) :534 - 539.
  • 8ALBERT MA, DANIELSON E, RIFAI N, et al. Effect of statin therapy on Creative protein levels: the pravastatin inflammation/ CRP evaluation ( PRINCE ) : a randomized trial and cohort study [ J]. JAMA,2001,286( 1 ) :64 -70.
  • 9KENT SM, FLAHERTY PJ, COYLE LC, et al. Effect of atorvastatin and pravastatin on serum C reactive protein [ J ]. Am Heart J,2003,145(2) :e8.
  • 10Oliveira MS,f'arvalho Jl.,Campos AC,et al. Doxorubicin has in vivo toxicological effects on ex vivo cultured mesenchymalstem cells[J].Toxicol Lett, 2014,224 (3) .. 380-- 386.

引证文献7

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部